
|Articles|November 3, 2021
Pharmacy Clinical Pearl of the Day: Cystic Fibrosis
Author(s)Saro Arakelians, PharmD
Cystic fibrosis affects the cells that produce mucus, sweat, and digestive juices.
Advertisement
Clinical Pearl of the Day: Cystic Fibrosis
Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs, digestive system and other organs in the body.
Insight:
- CF affects the cells that produce mucus, sweat and digestive juices.
- These secreted fluids are normally thin and slippery. But in people with CF, a defective gene causes the secretions to become sticky and thick.
- Symptoms may include a persistent cough that produces thick mucus (sputum), wheezing, exercise intolerance, repeated lung infections, inflamed nasal passages or a stuffy nose, and recurrent sinusitis.
- Risk factors include family history and most common in white people of Northern European ancestry.
- Diagnosis includes newborn screening and older children, if not screened before.
- Treatment includes combination products such as Trikafta, Symdeko, Orkambi, and Kalydeco. Pulmonary rehabilitation may also be an option
- Surgery options include nasal and sinus surgery, oxygen therapy, non-invasive ventilation, feeding tube, bowel surgery, and lung transplant.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
2
Targeted α-Particle Radioligand Therapy Shows Promising Activity, Low Toxicity in SSTR2-Positive Neuroendocrine Tumors
3
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
4
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
5